JAK2 and leukemia: Taken together, these data imply that 1) the expansion properties of JAK2 mutated leukemic cells vary, 2) other subclones (e.g. KRASG12D) can grow out at the expense of the major JAK2 mutated clone, 3) JAK2 mutations can get lost while leukemia progresses.